What You Should Know:
- DirectTrust today announced it has acquired the assets of SAFE Identity (including Trust Framework), an industry consortium and certification body supporting identity assurance and cryptography in healthcare. Financial details of the acquisition were not disclosed.
- The acquisition substantially extends DirectTrust’s capabilities and services and is expected to enable new and expanded interoperability use cases.
Post-Acquisition Plans
As part of the
Read More
Osso VR Launches VR-based Surgical Proficiency Assessment Tool
What You Should Know:
- Osso VR, a San Francisco, CA-based virtual reality-based surgical training company, today announced the launch the of its VR-based multimodal assessment experiences. In addition to adding this capability within its platform, Osso’s platform has also launched in multiple new languages in addition to English, including Japanese, Spanish, German and French to broaden access in the 30+ countries in which it is currently utilized.
- Osso VR is the first surgical training
Read More
FDA Clears World’s First and Only Smart Knee Implant
What You Should Know:
- Zimmer Biomet Holdings, a global medical technology leader, and Canary Medical, a medical data company, announced U.S. Food and Drug Administration (FDA) De Novo classification grant and authorization to market the tibial extension for Persona IQ®, the world's first and only smart knee cleared by the FDA for total knee replacement surgery.
- Persona IQ® combines Zimmer Biomet’s proven and trusted knee implant, Persona® The Personalized Knee®, with Canary Medical’s
Read More
Fresenius Medical Invests Additional $25M in Biotech Platform Humacyte
What You Should Know:
Fresenius Medical Care (FMC) today announced its plans to invest an additional $25 million in clinical-stage biotechnology platform company Humacyte following the extension of its collaboration in June. Fresenius Medical Care acquired a stake in Humacyte in 2018 for $150M as part of a strategic partnership.
Following the merger of Humacyte with a special purpose acquisition company (SPAC), FMC is increasing its position in the newly combined
Read More
Sanas’ Accent-Matching Solution for BPOs Launches with $6M
What You Should Know:
- Today Sanas.ai – which has been operating under stealth for a couple of years – is launching and announcing seed funding. Their AI platform for audio matches the accent of the person you're speaking with to yours with no perceptible lag time. Top venture funds investing in the company's $5.5 million seed round include Human Capital, General Catalyst, Quiet Capital, and DN Capital. Speech industry veterans joining Sanas' Board of Advisors include Wendell Brown
Read More
MedStar Health, MercyOne, Moffitt Cancer Center, Others Double Down on Digital Transformation
What You Should Know:
- AVIA, the nation’s leading healthcare innovation network, today announced that the following six new health system Members joined the AVIA Network to accelerate their digital strategies and advance digital capabilities: Lee Health, LifeBridge Health, MedStar Health, MercyOne, Moffitt Cancer Center, Multicare. Additionally, AVIA had a record of 100% plus renewal rate from
Read More
Ontada, Merck Partner to Facilitate Real World Evidence Studies for Cancer Care
What You Should Know:
- Ontada, McKesson’s oncology and insights business, announced a strategic agreement with Merck, known as MSD outside the United States and Canada, that will facilitate the development of real-world research excellence and innovation. This agreement enables the two healthcare leaders to harness the power of real-world evidence (RWE) towards the common goal of improving patient outcomes and the quality of cancer care.
- Ontada and Merck’s combined experience and
Read More
Nearly Half of Americans Have Experienced Challenges Obtaining Specialty Medications
What You Should Know:
- RxBenefits, the employee benefits industry’s first and only technology-enabled pharmacy benefits optimizer (PBO), announced the results of a new study which reveals that 73% of Americans are currently covered by their employers health benefits plan with prescription drug coverage, with 80% stating it is very or somewhat important that their current or future employer cover the cost of their -- or their family members -- specialty medications.
- The survey was
Read More
Mayo Clinic, Verily Partner to Develop Clinical Decision Support Solutions
What You Should Know:
- Today, Mayo Clinic and Verily, an Alphabet company announced a strategic two-year collaboration to develop clinical decision support solutions. This modular, evidence-based decision support solution, will provide contextualized and validated knowledge on disease management, care guidelines, and treatment to help clinicians make decisions.
- The clinical decision support tool will be developed based on a broad range of health-relevant data sources, including
Read More
Curebase, AppliedVR Partner on Multiple VR Therapy Clinical Trials
What You Should Know:
- Curebase, a company committed to democratizing access to clinical studies, and AppliedVR, a pioneer advancing the next generation of digital medicine, today announced a one-year partnership where AppliedVR will deploy the Curebase platform to run five clinical trials assessing the effectiveness of virtual reality-based (VR) therapy to treat chronic pain.
- AppliedVR is the most evidence-based therapeutic VR platform for pain management and has been used by
Read More
